細胞・遺伝子治療バイオ分析検査サービスの世界市場：規模、シェア、動向、産業分析 - 検査タイプ別、製品タイプ別、開発段階別、疾患別、地域別、セグメント予測（2024年～2032年）

Polaris Market Researchの最新調査によると、細胞・遺伝子治療バイオ分析検査サービス市場規模は2032年までに9億5,006万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

細胞療法や遺伝子療法が複数の疾患を治療できることを明らかにする研究件数の増加が、医療業界における研究活動への投資を促進しています。市場では、薬や医療機器の検査能力を高めるための政府の資金援助が行われています。例えば、2023年3月、英国政府は国民保健サービス血液・移植（NHSBT）が新しい細胞・遺伝子療法の開発・製造のための臨床バイオテクノロジーセンター（CBC）と呼ばれる新施設を開設するために1,000万米ドルを助成すると発表しました。さらに、世界中でがん患者が増加していることから、各国は細胞・遺伝子治療研究への投資を重視しています。インドや中国といった人口の多い国は、がん治療のための新しい治療法を発表しています。例えば、2024年4月、タタ記念センターとインド工科大学（IIT）ボンベイ校は、がん治療のためにインドで初めて開発されたCAR-T細胞療法を開始しました。このように新しい細胞療法は、細胞・遺伝子治療バイオ分析検査サービスの需要を押し上げ、市場成長に寄与しています。

細胞療法と遺伝子療法の設計と生産への投資を増やす製薬会社のイニシアティブの高まりは、性能評価ツールとサービスの需要を促進しており、これは世界市場にプラスの影響を与えています。例えば、2024年2月、Azzur Groupは、細胞・遺伝子治療開発の一環として、分析ラボ検査サービスを新たに提供することを発表しました。これは特に、先進的な治療薬やその他の医療製品を検査するためのものです。慢性疾患の増加により、研究者たちは効果的な薬剤の開発に励んでいます。細胞治療や遺伝子治療の開発が進むにつれ、人々の健康問題の治療が効果的に行われるようになっています。食品医薬品局（FDA）によると、鎌状赤血球症に苦しむ人は10万人にのぼるといいます。そのため、世界中で新しい治療法が考案されています。2023年12月、米国FDAは鎌状赤血球症の治療薬として2つの遺伝子治療薬のライフゲニアとキャスジェヴィの承認を発表しました。

細胞・遺伝子治療バイオ分析検査サービス市場レポートハイライト

バイオアベイラビリティ・生物学的同等性検査セグメントは、検査タイプ別に見ると、医薬品イノベーション活動の高まりにより、予測期間中に最も高い成長率を示すと予測されます。

製品タイプ別では、いくつかの疾患に対する細胞療法の生産が増加していることから、細胞療法セグメントが2023年に最大の市場シェアを占めました。

アジア太平洋は、バイオテクノロジー産業への投資の増加により、予測期間中に最も高い成長を記録すると予測されています。

欧州は、先端治療研究への投資の増加により、予測期間中に細胞・遺伝子治療バイオ分析検査サービス市場で大きなCAGRを記録すると予測されています。

BioAgilytix Labs、Charles River Laboratories、Intertek Group、IQVIA、KCAS Bioanalytical Services、Pharmaronなどが世界の市場企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の細胞・遺伝子治療バイオ分析検査サービス市場の洞察

• 用途スナップショット
• 細胞・遺伝子治療バイオ分析検査サービス市場力学
  • 促進要因と機会
    • 細胞・遺伝子治療の開発への投資増加が市場の成長を促進
    • 細胞・遺伝子治療の開発拡大が市場成長を牽引
  • 抑制要因と課題
    • 厳しい規制が市場の成長を妨げる
• PESTEL分析
• 細胞・遺伝子治療バイオ分析検査サービス市場の用途動向
• バリューチェーン分析
• COVID-19の影響分析

第5章 世界の細胞・遺伝子治療バイオ分析検査サービス市場：検査タイプ別

• 主な調査結果
• イントロダクション
• バイオアベイラビリティ・生物学的同等性の研究
• 薬物動態
• 薬力学
• その他

第6章 世界の細胞・遺伝子治療バイオ分析検査サービス市場：製品タイプ別

• 主な調査結果
• イントロダクション
• 遺伝子治療
• 遺伝子組み換え細胞療法
• 細胞療法

第7章 世界の細胞・遺伝子治療バイオ分析検査サービス市場：開発段階別

• 主な調査結果
• イントロダクション
• 非臨床
• 臨床

第8章 世界の細胞・遺伝子治療バイオ分析検査サービス市場：疾患別

• 主な調査結果
• イントロダクション
• 感染症
• 神経疾患
• 腫瘍学
• 希少疾患
• その他

第9章 世界の細胞・遺伝子治療バイオ分析検査サービス市場：地域別

• 主な調査結果
• イントロダクション
  • 細胞・遺伝子治療バイオ分析検査サービス市場評価：地域別（2019年～2032年）
• 北米
  • 北米：検査タイプ別（2019年～2032年）
  • 北米：製品タイプ別（2019年～2032年）
  • 北米：開発段階別（2019年～2032年）
  • 北米：疾患別（2019年～2032年）
  • 米国
  • カナダ
• 欧州
  • 欧州：検査タイプ別（2019年～2032年）
  • 欧州：製品タイプ別（2019年～2032年）
  • 欧州：開発段階別（2019年～2032年）
  • 欧州：症状別（2019年～2032年）
  • 英国
  • フランス
  • ドイツ
  • イタリア
  • スペイン
  • オランダ
  • ロシア
  • その他欧州
• アジア太平洋
  • アジア太平洋：検査タイプ別（2019年～2032年）
  • アジア太平洋：製品タイプ別（2019年～2032年）
  • アジア太平洋：開発段階別（2019年～2032年）
  • アジア太平洋：疾患別（2019年～2032年）
  • 中国
  • インド
  • マレーシア
  • 日本
  • インドネシア
  • 韓国
  • オーストラリア
  • その他アジア太平洋
• 中東・アフリカ
  • 中東・アフリカ：検査タイプ別（2019年～2032年）
  • 中東・アフリカ：製品タイプ別（2019年～2032年）
  • 中東・アフリカ：開発段階別（2019年～2032年）
  • 中東・アフリカ：疾患別（2019年～2032年）
  • サウジアラビア
  • アラブ首長国連邦
  • イスラエル
  • 南アフリカ
  • その他中東・アフリカ
• ラテンアメリカ
  • ラテンアメリカ：検査タイプ別（2019年～2032年）
  • ラテンアメリカ：製品タイプ別（2019年～2032年）
  • ラテンアメリカ：開発段階別（2019年～2032年）
  • ラテンアメリカ：疾患別（2019年～2032年）
  • メキシコ
  • ブラジル
  • アルゼンチン
  • その他ラテンアメリカ

第10章 競合情勢

• 事業拡大と買収の分析
  • 事業拡大
  • 買収
• 提携/協業/契約/公開

第11章 企業プロファイル

• BioAgilytix Labs
• Charles River Laboratories
• Intertek Group Plc.
• IQVIA, Inc.
• KCAS Bioanalytical Services
• Laboratory Corporation of America Holdings
• Pharmaron
• Pharmaceutical Product Development, Inc.
• Prolytix
• SGS SA
• Syneos Health

List of Tables

• Table 1 Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
• Table 2 Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
• Table 3 Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
• Table 4 Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
• Table 5 North America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
• Table 6 North America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
• Table 7 North America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
• Table 8 North America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
• Table 9 U.S.: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
• Table 10 U.S.: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
• Table 11 U.S.: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
• Table 12 U.S.: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
• Table 13 Canada: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
• Table 14 Canada: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
• Table 15 Canada: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
• Table 16 Canada: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
• Table 17 Europe: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
• Table 18 Europe: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
• Table 19 Europe: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
• Table 20 Europe: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
• Table 21 UK: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
• Table 22 UK: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
• Table 23 UK: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
• Table 24 UK: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
• Table 25 France: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
• Table 26 France: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
• Table 27 France: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
• Table 28 France: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
• Table 29 Germany: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
• Table 30 Germany: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
• Table 31 Germany: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
• Table 32 Germany: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
• Table 33 Italy: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
• Table 34 Italy: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
• Table 35 Italy: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
• Table 36 Italy: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
• Table 37 Spain: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
• Table 38 Spain: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
• Table 39 Spain: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
• Table 40 Spain: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
• Table 41 Netherlands: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
• Table 42 Netherlands: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
• Table 43 Netherlands: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
• Table 44 Netherlands: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
• Table 45 Russia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
• Table 46 Russia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
• Table 47 Russia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
• Table 48 Russia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
• Table 49 Rest of Europe: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
• Table 50 Rest of Europe: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
• Table 51 Rest of Europe: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
• Table 52 Rest of Europe: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
• Table 53 Asia Pacific: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
• Table 54 Asia Pacific: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
• Table 55 Asia Pacific: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
• Table 56 Asia Pacific: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
• Table 57 China: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
• Table 58 China: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
• Table 59 China: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
• Table 60 China: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
• Table 61 India: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
• Table 62 India: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
• Table 63 India: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
• Table 64 India: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
• Table 65 Malaysia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
• Table 66 Malaysia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
• Table 67 Malaysia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
• Table 68 Malaysia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
• Table 69 Japan: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
• Table 70 Japan: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
• Table 71 Japan: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
• Table 72 Japan: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
• Table 73 Indonesia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
• Table 74 Indonesia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
• Table 75 Indonesia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
• Table 76 Indonesia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
• Table 77 South Korea: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
• Table 78 South Korea: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
• Table 79 South Korea: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
• Table 80 South Korea: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
• Table 81 Australia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
• Table 82 Australia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
• Table 83 Australia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
• Table 84 Australia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
• Table 85 Rest of Asia Pacific: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
• Table 86 Rest of Asia Pacific: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
• Table 87 Rest of Asia Pacific: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
• Table 88 Rest of Asia Pacific: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
• Table 89 Middle East & Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
• Table 90 Middle East & Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
• Table 91 Middle East & Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
• Table 92 Middle East & Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
• Table 93 Saudi Arabia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
• Table 94 Saudi Arabia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
• Table 95 Saudi Arabia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
• Table 96 Saudi Arabia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
• Table 97 UAE: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
• Table 98 UAE: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
• Table 99 UAE: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
• Table 100 UAE: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
• Table 101 Israel: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
• Table 102 Israel: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
• Table 103 Israel: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
• Table 104 Israel: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
• Table 105 South Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
• Table 106 South Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
• Table 107 South Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
• Table 108 South Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
• Table 109 Rest of Middle East & Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
• Table 110 Rest of Middle East & Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
• Table 111 Rest of Middle East & Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
• Table 112 Rest of Middle East & Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
• Table 113 Latin America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
• Table 114 Latin America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
• Table 115 Latin America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
• Table 116 Latin America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
• Table 117 Mexico: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
• Table 118 Mexico: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
• Table 119 Mexico: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
• Table 120 Mexico: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
• Table 121 Brazil: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
• Table 122 Brazil: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
• Table 123 Brazil: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
• Table 124 Brazil: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
• Table 125 Argentina: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
• Table 126 Argentina: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
• Table 127 Argentina: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
• Table 128 Argentina: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
• Table 129 Rest of Latin America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
• Table 130 Rest of Latin America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
• Table 131 Rest of Latin America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
• Table 132 Rest of Latin America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)

List of Figures

• Figure 1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, 2019-2032 (USD Million)
• Figure 2. Integrated Ecosystem
• Figure 3. Research Methodology: Top-Down & Bottom-Up Price
• Figure 4. Market by Geography
• Figure 5. Porter's Five Forces
• Figure 6. Market by Test Type
• Figure 7. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2023 & 2032 (USD Million)
• Figure 8. Market by Product Type
• Figure 9. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2023 & 2032 (USD Million)
• Figure 10. Market by Stage of Development
• Figure 11. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2023 & 2032 (USD Million)
• Figure 12. Market by Indication
• Figure 13. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2023 & 2032 (USD Million)

The cell & gene therapy bioanalytical testing services market size is expected to reach USD 950.06 million by 2032, according to a new study by Polaris Market Research. The report "Cell & Gene Therapy Bioanalytical Testing Services Market Share, Size, Trends, Industry Analysis Report - By Test Type (Bioavailability & Bioequivalence Studies, Pharmacokinetics, Pharmacodynamics, and Others), By Product Type, By Stage of Development, By Indication, and By Region; Segment Forecast, 2023-2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The growing number of studies revealing the ability of cell and gene therapies to treat multiple diseases is driving investments in research activities in the healthcare industry. The government funding to increase its capacity to test medication and healthcare equipment in the marketplace. For instance, in March 2023, the UK government announced a grant of USD 10 million for the National Health Service Blood and Transplant (NHSBT) to open a new facility called the Clinical Biotechnology Centre (CBC) for the development and manufacturing of new cell and gene therapies. Furthermore, the growing number of cancer cases across the world is significantly emphasizing countries to invest in cell and gene therapy research. The most populous nations, such as India and China, are launching new therapies for the cancer treatment. For instance, in April 2024, Tata Memorial Centre & Indian Institute of Technology (IIT), Bombay launched India's first developed CAR-T cell therapy for cancer treatment. Thus new cell therapy is boosting demand for cell & gene therapy bioanalytical testing services, which is contributing to market growth.

The rising pharmaceutical companies' initiatives to increase investments in the design and production of cell and gene therapies are driving the demand for performance-evaluating tools and services, which is positively influencing the global market. For instance, in February 2024, Azzur Group announced the new offering of analytical laboratory testing services as a part of developing cell and gene therapy. This is specifically to test advanced therapeutics and other medical products. The increasing prevalence of chronic diseases is encouraging researchers to innovate effective medications. The growing development of cell and gene therapies effectively performs in treating health issues among the population. According to the Food and Drug Administration (FDA), ~100,000 people are suffering from sickle cell disease. This contributed to the design of new therapies around the world. In December 2023, the US FDA announced approval for two gene therapies-Lyfgenia & Casgevy-for the treatment of sickle cell disease.

Cell & Gene Therapy Bioanalytical Testing Services Market Report Highlights

The bioavailability & bioequivalence studies segment, by test type is anticipated to witness the highest growth rate during the forecast period due to rising drug innovation activities.

In terms of product type, the cell therapy segment accounted for the largest market share in 2023, owing to the increasing production of cell therapies for several diseases.

APAC is projected to register the highest growth during the forecast period, attributable to the growing investments in the biotechnological industry.

Europe is expected to register a significant CAGR in the cell & gene therapy bioanalytical testing services market during the forecast period due to due increased investment in advanced therapeutic research.

BioAgilytix Labs, Charles River Laboratories, Intertek Group, IQVIA, KCAS Bioanalytical Services, and Pharmaron are among the global market players.

Polaris Market Research has segmented the cell & gene therapy bioanalytical testing services market report on the basis of test type, product type, stage of development, indication, and region:

By Test Type Outlook (Revenue - USD million, 2019-2032)

• Bioavailability & Bioequivalence Studies
• Pharmacokinetics
• Pharmacodynamics
• Others

By Product Type Outlook (Revenue - USD million, 2019-2032)

• Gene Therapy
• Gene-Modified Cell Therapy
• Cell Therapy

By Stage of Development Outlook (Revenue - USD million, 2019-2032)

• Nonclinical
• Clinical

By Indication Outlook (Revenue - USD million, 2019-2032)

• Oncology
• Infectious Diseases
• Neurological Disorders
• Rare Diseases
• Others

By Regional Outlook (Revenue - USD million, 2019-2032)

• North America
• US
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• Russia
• Netherlands
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Malaysia
• Latin America
• Argentina
• Brazil
• Mexico
• Middle East & Africa
• UAE
• Saudi Arabia
• Israel
• South Africa

Table of Contents

1. Introduction

• 1.1. Report Description
  • 1.1.1. Objectives of the Study
  • 1.1.2. Market Scope
  • 1.1.3. Assumptions
• 1.2. Stakeholders

2. Executive Summary

• 2.1. Market Highlights

3. Research Methodology

• 3.1. Overview
  • 3.1.1. Data Mining
• 3.2. Data Sources
  • 3.2.1. Primary Sources
  • 3.2.2. Secondary Sources

4. Global Cell & Gene Therapy Bioanalytical Testing Services Market Insights

• 4.1. Cell & Gene Therapy Bioanalytical Testing Services Market - Application Snapshot
• 4.2. Cell & Gene Therapy Bioanalytical Testing Services Market Dynamics
  • 4.2.1. Drivers and Opportunities
    • 4.2.1.1. Rising Investments in Cell and Gene Therapy Developments Drive the Market Growth
    • 4.2.1.2. Growing Development of Cell and Gene Therapies Drives Market Growth
  • 4.2.2. Restraints and Challenges
    • 4.2.2.1. Stringent Regulations Hinders the Market Growth
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers (Moderate)
  • 4.3.2. Threats of New Entrants: (Low)
  • 4.3.3. Bargaining Power of Buyers (Moderate)
  • 4.3.4. Threat of Substitute (Moderate)
  • 4.3.5. Rivalry among existing firms (High)
• 4.4. PESTEL Analysis
• 4.5. Cell & Gene Therapy Bioanalytical Testing Services Market Application Trends
• 4.6. Value Chain Analysis
• 4.7. COVID-19 Impact Analysis

5. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type

• 5.1. Key Findings
• 5.2. Introduction
  • 5.2.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
• 5.3. Bioavailability & Bioequivalence Studies
  • 5.3.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Bioavailability & Bioequivalence Studies, by Region, 2019-2032 (USD Million)
• 5.4. Pharmacokinetics
  • 5.4.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Pharmacokinetics, by Region, 2019-2032 (USD Million)
• 5.5. Pharmacodynamics
  • 5.5.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Pharmacodynamics, by Region, 2019-2032 (USD Million)
• 5.6. Others
  • 5.6.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Others, by Region, 2019-2032 (USD Million)

6. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type

• 6.1. Key Findings
• 6.2. Introduction
  • 6.2.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
• 6.3. Gene Therapy
  • 6.3.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Gene Therapy, by Region, 2019-2032 (USD Million)
• 6.4. Gene-Modified Cell Therapy
  • 6.4.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Gene-Modified Cell Therapy, by Region, 2019-2032 (USD Million)
• 6.5. Cell Therapy
  • 6.5.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Cell Therapy, by Region, 2019-2032 (USD Million)

7. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development

• 7.1. Key Findings
• 7.2. Introduction
  • 7.2.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
• 7.3. Nonclinical
  • 7.3.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Nonclinical, by Region, 2019-2032 (USD Million)
• 7.4. Clinical
  • 7.4.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Clinical, by Region, 2019-2032 (USD Million)

8. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication

• 8.1. Key Findings
• 8.2. Introduction
  • 8.2.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
• 8.3. Infectious Diseases
  • 8.3.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Infectious Diseases, by Region, 2019-2032 (USD Million)
• 8.4. Neurological disorders
  • 8.4.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Neurological disorders, by Region, 2019-2032 (USD Million)
• 8.5. Oncology
  • 8.5.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Oncology, by Region, 2019-2032 (USD Million)
• 8.6. Rare Diseases
  • 8.6.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Rare Diseases, by Region, 2019-2032 (USD Million)
• 8.7. Others
  • 8.7.1. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Others, by Region, 2019-2032 (USD Million)

9. Global Cell & Gene Therapy Bioanalytical Testing Services Market, by Geography

• 9.1. Key Findings
• 9.2. Introduction
  • 9.2.1. Cell & Gene Therapy Bioanalytical Testing Services Market Assessment, By Geography, 2019-2032 (USD Million)
• 9.3. Cell & Gene Therapy Bioanalytical Testing Services Market - North America
  • 9.3.1. North America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
  • 9.3.2. North America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
  • 9.3.3. North America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
  • 9.3.4. North America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
  • 9.3.5. Cell & Gene Therapy Bioanalytical Testing Services Market - U.S.
    • 9.3.5.1. U.S.: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
    • 9.3.5.2. U.S.: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
    • 9.3.5.3. U.S.: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
    • 9.3.5.4. U.S.: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
  • 9.3.6. Cell & Gene Therapy Bioanalytical Testing Services Market - Canada
    • 9.3.6.1. Canada: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
    • 9.3.6.2. Canada: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
    • 9.3.6.3. Canada: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
    • 9.3.6.4. Canada: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
• 9.4. Cell & Gene Therapy Bioanalytical Testing Services Market - Europe
  • 9.4.1. Europe: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
  • 9.4.2. Europe: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
  • 9.4.3. Europe: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
  • 9.4.4. Europe: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
  • 9.4.5. Cell & Gene Therapy Bioanalytical Testing Services Market - UK
    • 9.4.5.1. UK: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
    • 9.4.5.2. UK: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
    • 9.4.5.3. UK: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
    • 9.4.5.4. UK: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
  • 9.4.6. Cell & Gene Therapy Bioanalytical Testing Services Market - France
    • 9.4.6.1. France: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
    • 9.4.6.2. France: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
    • 9.4.6.3. France: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
    • 9.4.6.4. France: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
  • 9.4.7. Cell & Gene Therapy Bioanalytical Testing Services Market - Germany
    • 9.4.7.1. Germany: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
    • 9.4.7.2. Germany: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
    • 9.4.7.3. Germany: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
    • 9.4.7.4. Germany: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
  • 9.4.8. Cell & Gene Therapy Bioanalytical Testing Services Market - Italy
    • 9.4.8.1. Italy: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
    • 9.4.8.2. Italy: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
    • 9.4.8.3. Italy: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
    • 9.4.8.4. Italy: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
  • 9.4.9. Cell & Gene Therapy Bioanalytical Testing Services Market - Spain
    • 9.4.9.1. Spain: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
    • 9.4.9.2. Spain: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
    • 9.4.9.3. Spain: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
    • 9.4.9.4. Spain: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
  • 9.4.10. Cell & Gene Therapy Bioanalytical Testing Services Market - Netherlands
    • 9.4.10.1. Netherlands: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
    • 9.4.10.2. Netherlands: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
    • 9.4.10.3. Netherlands: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
    • 9.4.10.4. Netherlands: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
  • 9.4.11. Cell & Gene Therapy Bioanalytical Testing Services Market - Russia
    • 9.4.11.1. Russia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
    • 9.4.11.2. Russia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
    • 9.4.11.3. Russia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
    • 9.4.11.4. Russia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
  • 9.4.12. Cell & Gene Therapy Bioanalytical Testing Services Market - Rest of Europe
    • 9.4.12.1. Rest of Europe: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
    • 9.4.12.2. Rest of Europe: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
    • 9.4.12.3. Rest of Europe: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
    • 9.4.12.4. Rest of Europe: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
• 9.5. Cell & Gene Therapy Bioanalytical Testing Services Market - Asia Pacific
  • 9.5.1. Asia Pacific: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
  • 9.5.2. Asia Pacific: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
  • 9.5.3. Asia Pacific: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
  • 9.5.4. Asia Pacific: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
  • 9.5.5. Cell & Gene Therapy Bioanalytical Testing Services Market - China
    • 9.5.5.1. China: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
    • 9.5.5.2. China: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
    • 9.5.5.3. China: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
    • 9.5.5.4. China: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
  • 9.5.6. Cell & Gene Therapy Bioanalytical Testing Services Market - India
    • 9.5.6.1. India: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
    • 9.5.6.2. India: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
    • 9.5.6.3. India: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
    • 9.5.6.4. India: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
  • 9.5.7. Cell & Gene Therapy Bioanalytical Testing Services Market - Malaysia
    • 9.5.7.1. Malaysia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
    • 9.5.7.2. Malaysia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
    • 9.5.7.3. Malaysia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
    • 9.5.7.4. Malaysia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
  • 9.5.8. Cell & Gene Therapy Bioanalytical Testing Services Market - Japan
    • 9.5.8.1. Japan: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
    • 9.5.8.2. Japan: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
    • 9.5.8.3. Japan: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
    • 9.5.8.4. Japan: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
  • 9.5.9. Cell & Gene Therapy Bioanalytical Testing Services Market - Indonesia
    • 9.5.9.1. Indonesia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
    • 9.5.9.2. Indonesia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
    • 9.5.9.3. Indonesia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
    • 9.5.9.4. Indonesia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
  • 9.5.10. Cell & Gene Therapy Bioanalytical Testing Services Market - South Korea
    • 9.5.10.1. South Korea: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
    • 9.5.10.2. South Korea: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
    • 9.5.10.3. South Korea: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
    • 9.5.10.4. South Korea: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
  • 9.5.11. Cell & Gene Therapy Bioanalytical Testing Services Market - Australia
    • 9.5.11.1. Australia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
    • 9.5.11.2. Australia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
    • 9.5.11.3. Australia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
    • 9.5.11.4. Australia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
  • 9.5.12. Cell & Gene Therapy Bioanalytical Testing Services Market - Rest of Asia Pacific
    • 9.5.12.1. Rest of Asia Pacific: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
    • 9.5.12.2. Rest of Asia Pacific: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
    • 9.5.12.3. Rest of Asia Pacific: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
    • 9.5.12.4. Rest of Asia Pacific: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
• 9.6. Cell & Gene Therapy Bioanalytical Testing Services Market - Middle East & Africa
  • 9.6.1. Middle East & Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
  • 9.6.2. Middle East & Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
  • 9.6.3. Middle East & Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
  • 9.6.4. Middle East & Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
  • 9.6.5. Cell & Gene Therapy Bioanalytical Testing Services Market - Saudi Arabia
    • 9.6.5.1. Saudi Arabia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
    • 9.6.5.2. Saudi Arabia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
    • 9.6.5.3. Saudi Arabia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
    • 9.6.5.4. Saudi Arabia: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
  • 9.6.6. Cell & Gene Therapy Bioanalytical Testing Services Market - UAE
    • 9.6.6.1. UAE: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
    • 9.6.6.2. UAE: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
    • 9.6.6.3. UAE: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
    • 9.6.6.4. UAE: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
  • 9.6.7. Cell & Gene Therapy Bioanalytical Testing Services Market - Israel
    • 9.6.7.1. Israel: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
    • 9.6.7.2. Israel: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
    • 9.6.7.3. Israel: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
    • 9.6.7.4. Israel: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
  • 9.6.8. Cell & Gene Therapy Bioanalytical Testing Services Market - South Africa
    • 9.6.8.1. South Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
    • 9.6.8.2. South Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
    • 9.6.8.3. South Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
    • 9.6.8.4. South Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
  • 9.6.9. Cell & Gene Therapy Bioanalytical Testing Services Market - Rest of Middle East & Africa
    • 9.6.9.1. Rest of Middle East & Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
    • 9.6.9.2. Rest of Middle East & Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
    • 9.6.9.3. Rest of Middle East & Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
    • 9.6.9.4. Rest of Middle East & Africa: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
• 9.7. Cell & Gene Therapy Bioanalytical Testing Services Market - Latin America
  • 9.7.1. Latin America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
  • 9.7.2. Latin America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
  • 9.7.3. Latin America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
  • 9.7.4. Latin America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
  • 9.7.5. Cell & Gene Therapy Bioanalytical Testing Services Market - Mexico
    • 9.7.5.1. Mexico: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
    • 9.7.5.2. Mexico: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
    • 9.7.5.3. Mexico: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
    • 9.7.5.4. Mexico: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
  • 9.7.6. Cell & Gene Therapy Bioanalytical Testing Services Market - Brazil
    • 9.7.6.1. Brazil: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
    • 9.7.6.2. Brazil: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
    • 9.7.6.3. Brazil: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
    • 9.7.6.4. Brazil: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
  • 9.7.7. Cell & Gene Therapy Bioanalytical Testing Services Market - Argentina
    • 9.7.7.1. Argentina: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
    • 9.7.7.2. Argentina: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
    • 9.7.7.3. Argentina: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
    • 9.7.7.4. Argentina: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)
  • 9.7.8. Cell & Gene Therapy Bioanalytical Testing Services Market - Rest of Latin America
    • 9.7.8.1. Rest of Latin America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Test Type, 2019-2032 (USD Million)
    • 9.7.8.2. Rest of Latin America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Product Type, 2019-2032 (USD Million)
    • 9.7.8.3. Rest of Latin America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Stage of Development, 2019-2032 (USD Million)
    • 9.7.8.4. Rest of Latin America: Cell & Gene Therapy Bioanalytical Testing Services Market, by Indication, 2019-2032 (USD Million)

10. Competitive Landscape

• 10.1. Expansion and Acquisition Analysis
  • 10.1.1. Expansion
  • 10.1.2. Acquisitions
• 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

• 11.1. BioAgilytix Labs
  • 11.1.1. Company Overview
  • 11.1.2. Financial Performance
  • 11.1.3. Product Benchmarking
  • 11.1.4. Recent Development
• 11.2. Charles River Laboratories
  • 11.2.1. Company Overview
  • 11.2.2. Financial Performance
  • 11.2.3. Product Benchmarking
  • 11.2.4. Recent Development
• 11.3. Intertek Group Plc.
  • 11.3.1. Company Overview
  • 11.3.2. Financial Performance
  • 11.3.3. Product Benchmarking
  • 11.3.4. Recent Development
• 11.4. IQVIA, Inc.
  • 11.4.1. Company Overview
  • 11.4.2. Financial Performance
  • 11.4.3. Product Benchmarking
  • 11.4.4. Recent Development
• 11.5. KCAS Bioanalytical Services
  • 11.5.1. Company Overview
  • 11.5.2. Financial Performance
  • 11.5.3. Product Benchmarking
  • 11.5.4. Recent Development
• 11.6. Laboratory Corporation of America Holdings
  • 11.6.1. Company Overview
  • 11.6.2. Financial Performance
  • 11.6.3. Product Benchmarking
  • 11.6.4. Recent Development
• 11.7. Pharmaron
  • 11.7.1. Company Overview
  • 11.7.2. Financial Performance
  • 11.7.3. Product Benchmarking
  • 11.7.4. Recent Development
• 11.8. Pharmaceutical Product Development, Inc.
  • 11.8.1. Company Overview
  • 11.8.2. Financial Performance
  • 11.8.3. Product Benchmarking
  • 11.8.4. Recent Development
• 11.9. Prolytix
  • 11.9.1. Company Overview
  • 11.9.2. Financial Performance
  • 11.9.3. Product Benchmarking
  • 11.9.4. Recent Development
• 11.10. SGS SA
  • 11.10.1. Company Overview
  • 11.10.2. Financial Performance
  • 11.10.3. Product Benchmarking
  • 11.10.4. Recent Development
• 11.11. Syneos Health
  • 11.11.1. Company Overview
  • 11.11.2. Financial Performance
  • 11.11.3. Product Benchmarking
  • 11.11.4. Recent Development